These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9877271)

  • 1. Analysis of rhG-CSF-effects on platelets by in vitro bleeding test and transcranial Doppler ultrasound examination.
    Söhngen D; Wienen S; Siebler M; Boogen C; Scheid C; Schulz A; Kobbe G; Diehl V; Heyll A
    Bone Marrow Transplant; 1998 Dec; 22(11):1087-90. PubMed ID: 9877271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administration of granulocyte-colony-stimulating factor for allogeneic hematopoietic cell collection may induce the tissue factor-dependent pathway in healthy donors.
    Topcuoglu P; Arat M; Dalva K; Ozcan M
    Bone Marrow Transplant; 2004 Jan; 33(2):171-6. PubMed ID: 14647251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. rhG-CSF effect on mixed lymphocyte cultures and circulating soluble HLA antigen levels in volunteer stem cell donors.
    Lindemann M; Rebmann V; Ottinger HD; Schmolke K; Kreuzfelder E; Grosse-Wilde H
    Exp Hematol; 2004 Nov; 32(11):1103-9. PubMed ID: 15539089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of rhG-CSF on platelets using in vitro bleeding time and transcranial Doppler examination].
    Söhngen D; Siebler M; Wienen S; Kobbe G; Hollmig K; Schneider P; Boogen C; Heyll A; Schneider W
    Beitr Infusionsther Transfusionsmed; 1997; 34():161-5. PubMed ID: 9417338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor.
    Cavallaro AM; Lilleby K; Majolino I; Storb R; Appelbaum FR; Rowley SD; Bensinger WI
    Bone Marrow Transplant; 2000 Jan; 25(1):85-9. PubMed ID: 10654020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective study of G-CSF effects on hemostasis in allogeneic blood stem cell donors.
    LeBlanc R; Roy J; Demers C; Vu L; Cantin G
    Bone Marrow Transplant; 1999 May; 23(10):991-6. PubMed ID: 10373063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Filgrastim mobilization and collection of allogeneic blood progenitor cells from adult family donors: first interim report of a prospective German multicenter study.
    Beelen DW; Ottinger H; Kolbe K; Pönisch W; Sayer HG; Knauf W; Stockschläder M; Scheid C; Schaefer UW
    Ann Hematol; 2002 Dec; 81(12):701-9. PubMed ID: 12483366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Autologous peripheral blood stem cells mobilization with etoposide plus rhG-CSF versus cyclophosphamide plus rhG-CSF].
    Shi YK; He XH; Han XH; Liu P; Yang JL; Zhou SY; Zhou AP; Zhang CG; Ai B
    Ai Zheng; 2003 Dec; 22(12):1311-6. PubMed ID: 14693058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mobilization of autologous peripheral blood stem cells by cyclophosphamide and recombinant human granulocyte colony-stimulating factor(rhG-CSF)].
    Shi Y; Zhou S; Han X
    Zhonghua Xue Ye Xue Za Zhi; 1998 Aug; 19(8):425-7. PubMed ID: 11189511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factor differently modifies actin polymerization in neutrophils.
    Zucca A; Brizzi S; Riccioni R; Azzarà A; Ghimenti M; Carulli G
    Clin Ter; 2006; 157(1):19-24. PubMed ID: 16669548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Safety of Short-Term Administration of Filgrastim (rhG-CSF) and Leukophresis Procedure in Healthy Children: Application of Peripheral Blood Stem Cell Collection in Pediatric Donors.
    Behfar M; Faghihi-Kashani S; Hosseini AS; Ghavamzadeh A; Hamidieh AA
    Biol Blood Marrow Transplant; 2018 Apr; 24(4):866-870. PubMed ID: 29284143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of factors for poor mobilization after administration of recombinant human granulocyte stimulating factor (rHuG-CSF) in healthy donors].
    Aoyama Y; Nakamae H; Yamamura R; Makita K; Shima E; Hasegawa T; Sakamoto C; Kho G; Ohta K; Yamane T; Takubo T; Hino M
    Gan To Kagaku Ryoho; 2003 Jun; 30(6):829-36. PubMed ID: 12852351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic effects of pegylated recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor on mobilization of hematopoietic progenitor and stem cells with long-term repopulating ability into peripheral blood in mice.
    Honda K; Takenaka K; Shinagawa K; Ishimaru F; Ikeda K; Niiya K; Harada M
    Bone Marrow Transplant; 2001 Aug; 28(4):329-34. PubMed ID: 11571503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mobilization of autologous peripheral blood stem cells by combined chemotherapy and rhG-CSF].
    Shi H; Gu X; Zhu L
    Zhonghua Zhong Liu Za Zhi; 2001 Mar; 23(2):159-61. PubMed ID: 11783025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human granulocyte colony-stimulating factor significantly decreases the expression of CXCR3 and CCR6 on T cells and preferentially induces T helper cells to a T helper 17 phenotype in peripheral blood harvests.
    Sun LX; Ren HY; Shi YJ; Wang LH; Qiu ZX
    Biol Blood Marrow Transplant; 2009 Jul; 15(7):835-43. PubMed ID: 19539215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GM-CSF-based mobilization effect in normal healthy donors for allogeneic peripheral blood stem cell transplantation.
    Sohn SK; Kim JG; Seo KW; Chae YS; Jung JT; Suh JS; Lee KB
    Bone Marrow Transplant; 2002 Jul; 30(2):81-6. PubMed ID: 12132046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamics and pharmacokinetics of single doses of subcutaneous pegylated human G-CSF mutant (Ro 25-8315) in healthy volunteers: comparison with single and multiple daily doses of filgrastim.
    van Der Auwera P; Platzer E; Xu ZX; Schulz R; Feugeas O; Capdeville R; Edwards DJ
    Am J Hematol; 2001 Apr; 66(4):245-51. PubMed ID: 11279634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated hematopoietic stem and progenitor cell mobilization without depletion of the bone marrow stem and progenitor cell pool in mice after repeated administration of recombinant murine G-CSF.
    de Kruijf EJ; van Pel M; Hagoort H; Kruysdijk D; Molineux G; Willemze R; Fibbe WE
    Hum Immunol; 2007 May; 68(5):368-74. PubMed ID: 17462504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with granulocyte colony-stimulating factor-induced peripheral blood stem cell yield in healthy donors.
    Suzuya H; Watanabe T; Nakagawa R; Watanabe H; Okamoto Y; Onishi T; Abe T; Kawano Y; Kagami S; Takaue Y
    Vox Sang; 2005 Nov; 89(4):229-35. PubMed ID: 16262756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.